With almost 30 years of international experience in the biopharmaceutical and medical industries, Charles Ruban is an expert in international healthcare. Charles has worked in a number of key positions throughout his career, and has led and contributed to the development of several major healthcare companies. He’s also developed strategic alliances, and launched therapeutic biologics in major pharmaceutical markets such as Europe, the US and Japan.
Prior to joining Verdot, Charles was Deputy CEO of HTL Biotechnology, a leader in the development and production of medical biopolymers. Before that, he was COO of DBV Technologies, where he supported its development in France and the US.
After starting his professional career in 1995 at Eurogroup Consulting, Charles spent 9 years (2003-2012) at Stallergenes, where he developed his biopharmaceutical expertise.
Charles graduated from the Ecole Centrale de Lyon and holds a Master’s degree in Biological and Medical Engineering from the Université Claude Bernard Lyon 1. He also achieved an Executive MBA at INSEAD in 2008.